Problem Solved? An Individual Ratio between Point-of-Care and Venous International Normalized Ratio Values in Two Patients with Antiphospholipid Syndrome: Two Case Reports
- PMID: 40115662
- PMCID: PMC11924302
- DOI: 10.1055/a-2542-5358
Problem Solved? An Individual Ratio between Point-of-Care and Venous International Normalized Ratio Values in Two Patients with Antiphospholipid Syndrome: Two Case Reports
Abstract
Antiphospholipid syndrome (APS) is a rare autoimmune disorder characterized by thromboembolic and obstetric complications in the presence of persistent antiphospholipid antibodies (aPL). Treatment aims to prevent recurrent thrombosis, primarily using anticoagulation therapy with vitamin K antagonists (VKA). Monitoring of VKA therapy relies on the International Normalized Ratio (INR), which can be assessed using point-of-care testing (POCT). However, in a subset of APS patients with a high-risk aPL profile, the POCT-INR is falsely elevated, which might lead to underdosing of VKA and subsequent high risk of recurrent thrombosis. This case report describes two female patients with triple-positive thrombotic APS receiving VKA therapy. Both patients underwent biweekly paired INR measurements via POCT-INR and venous INR methods. Despite significant discrepancies, a strong individual linear correlation was observed: r = 0.77 (95% confidence interval [CI]: 0.54-0.99, p < 0.001) and r = 0.93 (95% CI: 0.88-0.97, p < 0.001), respectively. These findings suggest that individualized correction factors could be developed to improve the accuracy of POCT-INR measurements, thereby optimizing VKA dosing in these patients.
Keywords: International Normalized Ratio; antiphospholipid syndrome; case report; point-of-care testing; vitamin-k antagonists.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).
Conflict of interest statement
Conflict of Interest None declared.
Figures

References
-
- ACR/EULAR APS Classification Criteria Collaborators . Barbhaiya M, Zuily S, Naden R et al.The 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol. 2023;75(10):1687–1702. - PubMed
-
- Knight J S, Branch D W, Ortel T L. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ. 2023;380:e069717. - PubMed
-
- Limper M, de Leeuw K, Lely A T et al.Diagnosing and treating antiphospholipid syndrome: a consensus paper. Neth J Med. 2019;77(03):98–108. - PubMed
-
- Shikdar S, Vashisht R, Bhattacharya P T. Treasure Island (FL): StatPearls Publishing LLC; 2024. International Normalized Ratio (INR)
-
- Gardiner C, Williams K, Mackie I J, Machin S J, Cohen H. Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol. 2005;128(02):242–247. - PubMed
Publication types
LinkOut - more resources
Full Text Sources